Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA5272828
Max Phase: Preclinical
Molecular Formula: C32H36ClN7O10S2
Molecular Weight: 778.27
Associated Items:
ID: ALA5272828
Max Phase: Preclinical
Molecular Formula: C32H36ClN7O10S2
Molecular Weight: 778.27
Associated Items:
Canonical SMILES: C[C@@H]1S[C@@H]2[C@H](NC(=O)/C(=N/OC(C)(C)C(=O)O)c3csc(N)n3)C(=O)N2C(C(=O)[O-])=C1C[N+]12CCC(CNC(=O)c3ccc(O)c(O)c3Cl)(CC1)C2
Standard InChI: InChI=1S/C32H36ClN7O10S2/c1-14-16(10-40-8-6-32(13-40,7-9-40)12-35-24(43)15-4-5-18(41)23(42)19(15)33)22(28(46)47)39-26(45)21(27(39)52-14)37-25(44)20(17-11-51-30(34)36-17)38-50-31(2,3)29(48)49/h4-5,11,14,21,27H,6-10,12-13H2,1-3H3,(H7-,34,35,36,37,38,41,42,43,44,46,47,48,49)/t14-,21+,27+,32?,40?/m0/s1
Standard InChI Key: VCTJOHQBGJCFCF-DNIWGAHESA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 778.27 | Molecular Weight (Monoisotopic): 777.1654 | AlogP: 0.21 | #Rotatable Bonds: 12 |
Polar Surface Area: 256.90 | Molecular Species: ACID | HBA: 14 | HBD: 6 |
#RO5 Violations: 3 | HBA (Lipinski): 17 | HBD (Lipinski): 7 | #RO5 Violations (Lipinski): 3 |
CX Acidic pKa: 2.73 | CX Basic pKa: 4.00 | CX LogP: -2.96 | CX LogD: -5.65 |
Aromatic Rings: 2 | Heavy Atoms: 52 | QED Weighted: 0.06 | Np Likeness Score: -0.01 |
1. Rayner B, Verderosa AD, Ferro V, Blaskovich MAT.. (2023) Siderophore conjugates to combat antibiotic-resistant bacteria., 14 (5): [PMID:37252105] [10.1039/d2md00465h] |
Source(1):